Hannah Fiji

Title: The Innovative Contributions of Inventor Hannah Fiji

Introduction

Hannah Fiji is a prominent inventor based in Fontana, CA (US), known for her groundbreaking work in the field of cancer therapeutics. With a total of three patents to her name, she has made significant strides in developing innovative solutions to combat cancer through her research and inventions.

Latest Patents

Hannah's latest patents include a nanodrug targeting protein geranylgeranylation. This invention relates to a liposome that can be a basic liposome, a transferrin-conjugated liposome, or a pH-sensitive liposome. These liposomes encapsulate a compound that specifically inhibits the activity of a protein prenyltransferase, such as RabGGTase and/or GGTase I. The liposomes can be utilized as anti-cancer therapeutics, including as part of methods for treating cancer, in assays, and in kits. Another notable patent is directed to novel compounds that inhibit the activity of protein prenyltransferases, including GGTase I and/or RabGGTase. These compounds also serve as anti-cancer therapeutics, contributing to methods for treating cancer, in assays, and in kits.

Career Highlights

Hannah has worked with esteemed institutions such as the University of California and Nof Corporation, where she has honed her skills and contributed to significant advancements in her field. Her work has been instrumental in the development of innovative cancer treatments.

Collaborations

Hannah has collaborated with notable colleagues, including Fuyuhiko Tamanoi and Ohyun Kwon, further enhancing her research and contributions to the field of cancer therapeutics.

Conclusion

Hannah Fiji's innovative contributions to cancer therapeutics through her patents and collaborations highlight her dedication to advancing medical science. Her work continues to inspire and pave the way for future innovations in the fight against cancer.